{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T18:25:29Z","timestamp":1792088729680,"version":"4.4.0"},"publisher-location":"Cham","reference-count":156,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783319511511","type":"print"},{"value":"9783319511528","type":"electronic"}],"license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016]]},"DOI":"10.1007\/7854_2016_28","type":"book-chapter","created":{"date-parts":[[2016,11,9]],"date-time":"2016-11-09T06:02:53Z","timestamp":1478671373000},"page":"45-70","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":191,"title":["Inflammation-Associated Co-morbidity Between Depression and Cardiovascular Disease"],"prefix":"10.1007","author":[{"given":"Angelos","family":"Halaris","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,11,10]]},"reference":[{"issue":"Suppl 1","key":"28_CR1","doi-asserted-by":"publisher","first-page":"3A","DOI":"10.1016\/j.amjcard.2009.10.007","volume":"105","author":"B Dahlof","year":"2010","unstructured":"Dahlof B (2010) Cardiovascular disease risk factors: epidemiology and risk assessment. Am J Cardiol 105(Suppl 1):3A\u20139A","journal-title":"Am J Cardiol"},{"issue":"4","key":"28_CR2","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1161\/CIRCULATIONAHA.109.192703","volume":"121","author":"DM Lloyd-Jones","year":"2010","unstructured":"Lloyd-Jones DM, Hong Y, Labarthe D et al (2010) Defining and setting national goals for cardiovascular health promotion and disease reduction. Circulation 121(4):586\u2013613","journal-title":"Circulation"},{"issue":"4","key":"28_CR3","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1038\/clpt.2011.213","volume":"90","author":"SA Waldman","year":"2011","unstructured":"Waldman SA, Terzic A (2011) Cardiovascular health: the global challenge. Clin Pharmacol Ther 90(4):483\u2013485","journal-title":"Clin Pharmacol Ther"},{"key":"28_CR4","volume-title":"Heart disease and stroke statistics","author":"American Heart Association","year":"2004","unstructured":"American Heart Association (2004) Heart disease and stroke statistics. American Heart Association, Dallas, TX"},{"issue":"Suppl 1","key":"28_CR5","first-page":"3","volume":"7","author":"JP Lepin","year":"2011","unstructured":"Lepin JP, Briley M (2011) The increasing burden of depression. Neuropsychiatr Dis Treat 7(Suppl 1):3\u20137","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"1","key":"28_CR6","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/nrn2297","volume":"9","author":"R Dantzer","year":"2008","unstructured":"Dantzer R, O\u2019Connor JC, Freund GG et al (2008) From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci 9(1):46\u201356","journal-title":"Nat Rev Neurosci"},{"key":"28_CR7","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1097\/YCO.0b013e328315a561","volume":"22","author":"TG Dinan","year":"2008","unstructured":"Dinan TG (2008) Inflammatory markers in depression. Curr Opin Psychiatry 22:32\u201336","journal-title":"Curr Opin Psychiatry"},{"key":"28_CR8","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/npp.2011.205","volume":"37","author":"E Haroon","year":"2012","unstructured":"Haroon E, Raison CL, Miller AH (2012) Psychoneuroimmunology Meets neuropsychopharmacology: translational implications of the impact of inflammation on behavior. Neuropsychopharmacol Rev 37:137\u2013162","journal-title":"Neuropsychopharmacol Rev"},{"issue":"3","key":"28_CR9","doi-asserted-by":"publisher","first-page":"205","DOI":"10.2174\/157339510791823835","volume":"6","author":"BE Leonard","year":"2010","unstructured":"Leonard BE (2010) The concept of depression as a dysfunction of the immune system. Curr Immunol Rev 6(3):205\u2013212","journal-title":"Curr Immunol Rev"},{"key":"28_CR10","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1097\/00045415-200101000-00007","volume":"9","author":"W Koenig","year":"2001","unstructured":"Koenig W (2001) Inflammation and coronary heart disease: an overview. Cardiol Rev 9:31\u201335","journal-title":"Cardiol Rev"},{"key":"28_CR11","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1136\/heart.87.3.201","volume":"87","author":"NT Mulvihill","year":"2002","unstructured":"Mulvihill NT, Foley JB (2002) Inflammation in acute coronary syndromes. Heart 87:201\u2013204","journal-title":"Heart"},{"issue":"Suppl 2","key":"28_CR12","first-page":"SII130","volume":"69","author":"M Robbins","year":"2002","unstructured":"Robbins M, Topol EJ (2002) Inflammation in acute coronary syndromes. Cleve Clin J Med 69(Suppl 2):SII130\u2013SII142","journal-title":"Cleve Clin J Med"},{"key":"28_CR13","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/S0002-9149(01)02264-0","volume":"89","author":"WJ Kop","year":"2002","unstructured":"Kop WJ, Gottdiener JS, Tangen CM et al (2002) Inflammation and coagulation factors on persons > 65 years of age with symptoms of depression but without evidence of myocardial ischemia. Am J Cardiol 89:419\u2013424","journal-title":"Am J Cardiol"},{"key":"28_CR14","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1176\/ajp.150.8.1189","volume":"150","author":"M Maes","year":"1993","unstructured":"Maes M, Bosmans E, Meltzer HY et al (1993) Interleukin-1 beta: a putative mediator of HPA axis hyperactivity in major depression? Am J Psychiatry 150:1189\u20131193","journal-title":"Am J Psychiatry"},{"key":"28_CR15","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/0165-0327(96)00044-4","volume":"40","author":"M Maes","year":"1996","unstructured":"Maes M, der Planken V, Van Gastel A, Desnyder R (1996) Blood coagulation and platelet aggression in major depression. J Affect Disord 40:35\u201340","journal-title":"J Affect Disord"},{"key":"28_CR16","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1176\/appi.ajp.158.8.1252","volume":"158","author":"DL Musselman","year":"2001","unstructured":"Musselman DL, Miller AH, Porter MR et al (2001) Higher than normal plasma interleukin-6 concentrations in cancer patients with depression: preliminary findings. Am J Psychiatry 158:1252\u20131257","journal-title":"Am J Psychiatry"},{"key":"28_CR17","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/S0889-1591(02)00008-9","volume":"16","author":"N Castanon","year":"2002","unstructured":"Castanon N, Leonard BE, Neveu PJ, Yirmiya R (2002) Effects of antidepressants on cytokine production and actions. Brain Behav Immun 16:569\u2013574","journal-title":"Brain Behav Immun"},{"key":"28_CR18","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/S0024-3205(97)00990-9","volume":"62","author":"TJ Connor","year":"1998","unstructured":"Connor TJ, Leonard BE (1998) Depression, stress and immunological activation: the role of cytokines in depressive disorders. Life Sci 62:583\u2013606","journal-title":"Life Sci"},{"key":"28_CR19","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/978-3-0348-8344-3_8","volume-title":"Antidepressants","author":"BE Leonard","year":"2001","unstructured":"Leonard BE (2001) Brain cytokines and the psychopathology of depression. In: Leonard BE (ed) Antidepressants. Birkhauser Verlag, Basel, pp 109\u2013120"},{"key":"28_CR20","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/BF03033243","volume":"10","author":"BE Leonard","year":"2006","unstructured":"Leonard BE, Myint AM (2006) Inflammation and depression: is there a causal connection with dementia? Neurotox Res 10:149\u2013160","journal-title":"Neurotox Res"},{"issue":"9063","key":"28_CR21","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1016\/S0140-6736(96)07495-8","volume":"349","author":"CJ Murray","year":"1997","unstructured":"Murray CJ, Lopez AD (1997) Global mortality, disability and the contribution of risk factors: global burden of disease study. Lancet 349(9063):1436\u20131442","journal-title":"Lancet"},{"key":"28_CR22","first-page":"1229","volume":"59","author":"Centers for Disease Control and Prevention (CDC)","year":"2010","unstructured":"Centers for Disease Control and Prevention (CDC) (2010) Current depression among adults\u2014United States, 2006 and 2008. Morb Mortal Wkly Rep 59:1229\u20131235","journal-title":"Morb Mortal Wkly Rep"},{"key":"28_CR23","doi-asserted-by":"publisher","first-page":"2581","DOI":"10.1001\/jama.291.21.2581","volume":"291","author":"K Demyttenaere","year":"2004","unstructured":"Demyttenaere K, Bruffaerts R, Posada-Villa J et al (2004) Prevalence, severity, and unmet need for treatment of mental disorders in the World Health Organization world mental health surveys. JAMA 291:2581\u20132590","journal-title":"JAMA"},{"key":"28_CR24","doi-asserted-by":"publisher","first-page":"2192","DOI":"10.1161\/01.CIR.99.16.2192","volume":"99","author":"A Rozanski","year":"1999","unstructured":"Rozanski A, Blumenthal JA, Kaplan J (1999) Impact of psychological factors on the pathogenesis of cardiovascular disease and implications for therapy. Circulation 99:2192\u20132217","journal-title":"Circulation"},{"key":"28_CR25","unstructured":"Pratt LA, Brody DJ (2014) Depression in the U.S. household population, 2009\u20132012 (NCHS data brief, no 172). National Center for Health Statistics, Hyattsville, MD"},{"issue":"4","key":"28_CR26","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1038\/clpt.2011.173","volume":"90","author":"JC Kovasic","year":"2011","unstructured":"Kovasic JC, Fuster V (2011) From treating complex coronary disease to promoting cardiovascular health: therapeutic transitions and challenges 2010-2020. Clin Pharmacol Ther 90(4):509\u2013518","journal-title":"Clin Pharmacol Ther"},{"key":"28_CR27","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1016\/j.ehj.2004.03.011","volume":"25","author":"JF Viles-Gonzalez","year":"2004","unstructured":"Viles-Gonzalez JF, Fuster V, Badimon JJ (2004) Atherothrombosis: a widespread disease with unpredictable and life-threatening consequences. Eur Heart J 25:1197\u20131207","journal-title":"Eur Heart J"},{"key":"28_CR28","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1111\/j.1752-8062.2011.00295.x","volume":"4","author":"A Terzic","year":"2011","unstructured":"Terzic A, Waldman SA (2011) Chronic diseases: the emerging pandemic. Clin Transl Sci 4:225\u2013226","journal-title":"Clin Transl Sci"},{"key":"28_CR29","unstructured":"CDC, NCHS (2015) Underlying cause of death 1999-2013 on CDC WONDER Online Database, released 2015. Data are from the Multiple Cause of Death Files, 1999-2013, as compiled from data provided by the 57 vital statistics jurisdictions through the Vital Statistics Cooperative Program. Accessed 3 Feb 2015"},{"key":"28_CR30","doi-asserted-by":"publisher","first-page":"e29","DOI":"10.1161\/CIR.0000000000000152","volume":"131","author":"D Mozaffarian","year":"2015","unstructured":"Mozaffarian D, Benjamin EJ, Go AS et al (2015) Heart disease and stroke statistics\u20142015 update: a report from the American Heart Association. Circulation 131:e29\u2013e322","journal-title":"Circulation"},{"key":"28_CR31","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1097\/01.psy.0000146332.53619.b2","volume":"66","author":"J Barth","year":"2004","unstructured":"Barth J, Schumacher M, Herrmann-Lingen C (2004) Depression as a risk factor for mortality in patients with coronary heart disease: a meta-analysis. Psychosom Med 66:802\u2013813","journal-title":"Psychosom Med"},{"key":"28_CR32","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1161\/01.STR.0000149626.50127.d0","volume":"36","author":"BB Gump","year":"2005","unstructured":"Gump BB, Matthews KA, Eberly LE, Chang YF (2005) MRFIT Research Group. Depressive symptoms and mortality in men: results from multiple risk factor intervention trial. Stroke 36:98\u2013102","journal-title":"Stroke"},{"key":"28_CR33","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1161\/01.CIR.102.15.1773","volume":"102","author":"AA Ariyo","year":"2000","unstructured":"Ariyo AA, Haan M, Tangen CM et al (2000) Depressive symptoms and risks of coronary heart disease and mortality in elderly Americans. Cardiovascular Health Study Collaborative Research Group. Circulation 102:1773\u20131779","journal-title":"Circulation"},{"issue":"13","key":"28_CR34","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1001\/archinte.158.13.1422","volume":"158","author":"DE Ford","year":"1998","unstructured":"Ford DE, Mead LA, Chang PP (1998) Depression is a risk factor for coronary artery disease in men: the precursors study. Arch Intern Med 158(13):1422\u20131426","journal-title":"Arch Intern Med"},{"key":"28_CR35","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1001\/archpsyc.58.3.221","volume":"58","author":"BW Penninx","year":"2001","unstructured":"Penninx BW, Beekman AT, Honig A et al (2001) Depression and cardiac mortality: results from a community-based longitudinal study. Arch Gen Psychiatry 58:221\u2013227","journal-title":"Arch Gen Psychiatry"},{"key":"28_CR36","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1001\/archinte.161.15.1849","volume":"161","author":"W Jiang","year":"2001","unstructured":"Jiang W, Alexander J, Christopher E et al (2001) Relationship of depression to increased risk of mortality and rehospitalization in patients with congestive heart failure. Arch Intern Med 161:1849\u20131856","journal-title":"Arch Intern Med"},{"key":"28_CR37","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1161\/hc0902.104707","volume":"105","author":"J Lesperance","year":"2002","unstructured":"Lesperance J, Frasure-Smith N, Talajic M, Bourassa M (2002) Five-year risk of cardiac mortality in relation to initial severity and one-year changes in depression symptoms in myocardial infarction. Circulation 105:1049\u20131053","journal-title":"Circulation"},{"key":"28_CR38","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.ejheart.2004.05.011","volume":"7","author":"J Junger","year":"2005","unstructured":"Junger J, Schellberg D, Muller-Tasch T (2005) Depression increasingly predicts mortality in the course of congestive heart failure. Eur J Heart Fail 7:261\u2013267","journal-title":"Eur J Heart Fail"},{"key":"28_CR39","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1001\/archinte.167.4.367","volume":"167","author":"A Sherwood","year":"2007","unstructured":"Sherwood A, Blumenthal JA, Trivedi R et al (2007) Relationship of depression to death or hospitalization in patients with heart failure. Arch Intern Med 167:367\u2013373","journal-title":"Arch Intern Med"},{"key":"28_CR40","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1001\/jama.288.6.750","volume":"288","author":"RM Carney","year":"2002","unstructured":"Carney RM, Jaffe AS (2002) Treatment of depression following acute myocardial infarction. JAMA 288:750\u2013751","journal-title":"JAMA"},{"key":"28_CR41","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1001\/archpsyc.55.7.580","volume":"55","author":"DL Musselman","year":"1998","unstructured":"Musselman DL, Evans DL, Nemeroff CB (1998) The relationship of depression to cardiovascular disease: epidemiology, biology, and treatment. Arch Gen Psychiatry 55:580\u2013592","journal-title":"Arch Gen Psychiatry"},{"key":"28_CR42","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1067\/mhj.2000.109979","volume":"140","author":"CM O\u2019Connor","year":"2000","unstructured":"O\u2019Connor CM, Gurbel PA, Serebruany VL (2000) Depression in ischemic heart disease. Am Heart J 140:63\u201369","journal-title":"Am Heart J"},{"key":"28_CR43","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1097\/01.psy.0000181274.56785.28","volume":"67","author":"LR Wulsin","year":"2005","unstructured":"Wulsin LR, Evans JC, Vasan RS et al (2005) Depressive symptoms, coronary heart disease, and overall mortality in the Framingham heart study. Psychosom Med 67:697\u2013702","journal-title":"Psychosom Med"},{"key":"28_CR44","unstructured":"Eaton WW, Fogel J, Armenian HK (2006) The consequences of psychopathology in the Baltimore Epidemiologic Catchment Area Follow-up. Medical and psychiatric co-morbidity over the lifespan. American Psychiatric Publishing, Washington, DC, p 21\u201338"},{"key":"28_CR45","doi-asserted-by":"publisher","first-page":"2763","DOI":"10.1093\/eurheartj\/ehl338","volume":"27","author":"A Nicholson","year":"2006","unstructured":"Nicholson A, Kuper H, Hemingway H (2006) Depression as an aetiologic and prognostic factor in coronary heart disease: a meta-analysis of 6362 events among 146 538 participants in 54 observational studies. Eur Heart J 27:2763\u20132774","journal-title":"Eur Heart J"},{"issue":"2","key":"28_CR46","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1097\/01.psy.0000208630.79271.a0","volume":"68","author":"JM McCaffery","year":"2006","unstructured":"McCaffery JM, Frasure-Smith N, Dube MP et al (2006) Common genetic vulnerability to depressive symptoms and coronary artery disease: a review and development of candidate genes related to inflammation and serotonin. Psychosom Med 68(2):187\u2013200","journal-title":"Psychosom Med"},{"key":"28_CR47","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1016\/0277-9536(91)90159-A","volume":"32","author":"R Fielding","year":"1991","unstructured":"Fielding R (1991) Depression and acute myocardial infarction: a review and reinterpretation. Soc Sci Med 32:1017\u20131027","journal-title":"Soc Sci Med"},{"key":"28_CR48","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/S0006-3223(03)00587-0","volume":"54","author":"B Rudisch","year":"2003","unstructured":"Rudisch B, Nemeroff CB (2003) Epidemiology of comorbid coronary artery disease and depression. Biol Psychiatry 54:227\u2013240","journal-title":"Biol Psychiatry"},{"key":"28_CR49","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1001\/archinte.1989.00390080059014","volume":"149","author":"SJ Schleifer","year":"1989","unstructured":"Schleifer SJ, Macari-Hinson MM, Coyle DA (1989) The nature and course of depression following myocardial infarction. Arch Intern Med 149:1785\u20131789","journal-title":"Arch Intern Med"},{"key":"28_CR50","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.1001\/jama.1993.03510150053029","volume":"270","author":"N Frasure-Smith","year":"1993","unstructured":"Frasure-Smith N, Lesperance F, Talajic M (1993) Depression following myocardial infarction: impact of 6-month survival. JAMA 270:1819\u20131825","journal-title":"JAMA"},{"key":"28_CR51","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1161\/01.CIR.91.4.999","volume":"91","author":"N Frasure-Smith","year":"1995","unstructured":"Frasure-Smith N, Lesperance F, Talajic M (1995) Depression and 18-month prognosis after myocardial infraction. Circulation 91:999\u20131005","journal-title":"Circulation"},{"key":"28_CR52","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/0002-9149(90)90736-K","volume":"66","author":"DK Ahern","year":"1990","unstructured":"Ahern DK, Gorkin L, Anderson JL et al (1990) Biobehavioral variables and mortality or cardiac arrest in the Cardiac Arrhythmia Pilot Study (CAPS). Am J Cardiol 66:59\u201362","journal-title":"Am J Cardiol"},{"key":"28_CR53","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/S0002-9149(01)01675-7","volume":"88","author":"DE Bush","year":"2001","unstructured":"Bush DE, Ziegelstein RC, Tayback M et al (2001) Even minimal symptoms of depression increase mortality risk after acute myocardial infection. Am J Cardiol 88:337\u2013341","journal-title":"Am J Cardiol"},{"key":"28_CR54","volume-title":"The stress of life","author":"H Selye","year":"1956","unstructured":"Selye H (1956) The stress of life. McGraw-Hill, New York"},{"issue":"2","key":"28_CR55","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1172\/JCI30555","volume":"117","author":"K Tracey","year":"2007","unstructured":"Tracey K (2007) Physiology and immunology of the cholinergic anti-inflammatory pathway. J Clin Invest 117(2):289\u2013296","journal-title":"J Clin Invest"},{"key":"28_CR56","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.biopsycho.2005.11.013","volume":"74","author":"JF Thayer","year":"2007","unstructured":"Thayer JF, Lane RD (2007) The role of vagal function in the risk for cardiovascular disease and mortality. Biol Psychol 74:224\u2013242","journal-title":"Biol Psychol"},{"key":"28_CR57","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.bbi.2005.03.015","volume":"19","author":"V Pavlov","year":"2005","unstructured":"Pavlov V, Tracey K (2005) The cholinergic anti-inflammatory pathway. Brain Behav Immun 19:493\u2013499","journal-title":"Brain Behav Immun"},{"issue":"1","key":"28_CR58","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.bbi.2008.06.011","volume":"23","author":"VA Pavlov","year":"2009","unstructured":"Pavlov VA, Parrish WR, Rosas-Ballina M et al (2009) Brain acetylcholinesterase activity controls systemic cytokine levels through the cholinergic anti-inflammatory pathway. Brain Behav Immun 23(1):41\u201345. doi:\n                  10.1016\/j.bbi.2008.06.011","journal-title":"Brain Behav Immun"},{"issue":"1-3","key":"28_CR59","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1007\/s12026-015-8718-1","volume":"63","author":"VA Pavlov","year":"2015","unstructured":"Pavlov VA, Tracey KJ (2015) Neural circuitry and immunity. Immunol Res 63(1-3):38\u201357","journal-title":"Immunol Res"},{"issue":"11","key":"28_CR60","doi-asserted-by":"publisher","first-page":"2139","DOI":"10.1176\/appi.ajp.162.11.2139","volume":"162","author":"C Otte","year":"2005","unstructured":"Otte C, Neylan TC, Pipkin SS et al (2005) Depressive symptoms and 24-hour urinary norepinephrine excretion levels in patients with coronary disease: findings from the heart and soul study. Am J Psychiatry 162(11):2139\u20132145","journal-title":"Am J Psychiatry"},{"issue":"11","key":"28_CR61","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1016\/j.biopsych.2009.12.012","volume":"67","author":"AH Kemp","year":"2010","unstructured":"Kemp AH, Quintana DS, Gray MA et al (2010) Impact of depression and antidepressant treatment on heart rate variability: a review and meta-analysis. Biol Psychiatry 67(11):1067\u20131074. doi:\n                  10.1016\/j.biopsych.2009.12.012\n                  \n                , Epub 6 Feb 2010","journal-title":"Biol Psychiatry"},{"issue":"12","key":"28_CR62","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1001\/archpsyc.65.12.1358","volume":"65","author":"CM Licht","year":"2008","unstructured":"Licht CM, de Geus EJC, Zitman FG et al (2008) Association between major depressive disorder and heart rate variability in the Netherlands study of depression and anxiety (NESDA). Arch Gen Psychiatry 65(12):1358\u20131367","journal-title":"Arch Gen Psychiatry"},{"issue":"2","key":"28_CR63","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/S0167-8760(01)00162-3","volume":"42","author":"SW Porges","year":"2001","unstructured":"Porges SW (2001) The polyvagal theory: phylogenetic substrates of a social nervous system. Int J Psychophysiol 42(2):123\u2013146","journal-title":"Int J Psychophysiol"},{"issue":"2","key":"28_CR64","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/0149-7634(94)00066-A","volume":"19","author":"SW Porges","year":"1995","unstructured":"Porges SW (1995) Cardiac vagal tone; a physiological index of stress. Neurosci Biobehav Rev 19(2):225\u2013233","journal-title":"Neurosci Biobehav Rev"},{"key":"28_CR65","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1111\/j.1749-6632.1997.tb51913.x","volume":"807","author":"SW Porges","year":"1997","unstructured":"Porges SW (1997) Emotion: an evolutionary by-product of the neural regulation of the autonomic nervous system. Ann N Y Acad Sci 807:62\u201377","journal-title":"Ann N Y Acad Sci"},{"key":"28_CR66","doi-asserted-by":"publisher","unstructured":"Licht CM, Penninx BW, de Geus EJ (2011) To include or not to include? A response to the meta-analysis of heart rate variability and depression. Biol Psychiatry 69(4):e1; author reply e3\u20134. doi:\n                  10.1016\/j.biopsych.2010.06.034","DOI":"10.1016\/j.biopsych.2010.06.034"},{"key":"28_CR67","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1111\/j.1742-4658.2012.08551.x","volume":"279","author":"AM Myint","year":"2012","unstructured":"Myint AM (2012) Kynurenines: from the perspective of major psychiatric disorders. FEBS J 279:1375\u20131385","journal-title":"FEBS J"},{"issue":"4","key":"28_CR68","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/0306-9877(91)90272-Z","volume":"35","author":"RS Smith","year":"1991","unstructured":"Smith RS (1991) The macrophage theory of depression. Med Hypotheses 35(4):298\u2013306","journal-title":"Med Hypotheses"},{"issue":"5","key":"28_CR69","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1007\/BF02195983","volume":"241","author":"E Ur","year":"1992","unstructured":"Ur E, Pd W, Grossman A (1992) Hypothesis: cytokines may be activated to cause depressive illness and chronic fatigue syndrome. Eur Arch Psychiatry Clin Neurosci 241(5):317\u2013322","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"28_CR70","first-page":"305","volume":"66","author":"HS Lett","year":"2004","unstructured":"Lett HS, Blumenthal JA, Babyak MA et al (2004) Depression as a risk factor for coronary artery disease: evidence, mechanisms, and treatment. Psychosom Med 66:305\u2013315","journal-title":"Psychosom Med"},{"key":"28_CR71","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/0006-3223(94)90652-1","volume":"36","author":"M Maes","year":"1994","unstructured":"Maes M (1994) Cytokines in major depression. Biol Psychiatry 36:498\u2013499","journal-title":"Biol Psychiatry"},{"key":"28_CR72","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1038\/sj.mp.4000436","volume":"4","author":"H Anisman","year":"1999","unstructured":"Anisman H, Ravindran AV, Griffiths J et al (1999) Endocrine and cytokine correlates of major depression and dysthymia with typical or atypical features. Mol Psychiatry 4:182\u2013188","journal-title":"Mol Psychiatry"},{"key":"28_CR73","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.jad.2005.03.012","volume":"87","author":"F Kaestner","year":"2005","unstructured":"Kaestner F, Hettich M, Peters M et al (2005) Different activation patterns of proinflammatory cytokines in melancholic and non-melancholic major depression are associated with HPA axis activity. J Affect Disord 87:305\u2013311","journal-title":"J Affect Disord"},{"key":"28_CR74","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1038\/sj.mp.4001084","volume":"7","author":"YK Kim","year":"2002","unstructured":"Kim YK, Suh IB, Kim H et al (2002) The plasma levels of interleukin-12 in schizophrenia, major depression, and bipolar mania: effects of psychotropic drugs. Mol Psychiatry 7:1107\u20131114","journal-title":"Mol Psychiatry"},{"key":"28_CR75","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/S0893-133X(99)00134-7","volume":"22","author":"S Lanquillon","year":"2000","unstructured":"Lanquillon S, Krieg JC, Bening-Abu-Shach U, Vedder H (2000) Cytokine production and treatment response in major depressive disorder. Neuropsychopharmacology 22:370\u2013379","journal-title":"Neuropsychopharmacology"},{"key":"28_CR76","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/S0924-977X(01)00081-5","volume":"11","author":"O Mikova","year":"2001","unstructured":"Mikova O, Yakimova R, Bosmans E et al (2001) Increased serum tumor necrosis factor alpha concentrations in major depression and multiple sclerosis. Eur Neuropsychopharmacol 11:203\u2013208","journal-title":"Eur Neuropsychopharmacol"},{"key":"28_CR77","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.jad.2005.07.008","volume":"88","author":"AM Myint","year":"2005","unstructured":"Myint AM, Leonard BE, Steinbusch HW, Kim YK (2005) Th1, Th2, and Th3 cytokine alterations in major depression. J Affect Disord 88:167\u2013173","journal-title":"J Affect Disord"},{"key":"28_CR78","doi-asserted-by":"publisher","first-page":"313","DOI":"10.3109\/15622970802573246","volume":"10","author":"JE Piletz","year":"2009","unstructured":"Piletz JE, Halaris A, Iqbal O et al (2009) Pro-inflammatory biomarkers in depression: treatment with venlafaxine. World J Biol Psychiatry 10:313\u2013323","journal-title":"World J Biol Psychiatry"},{"key":"28_CR79","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.pnpbp.2004.11.003","volume":"29","author":"OJ Schiepers","year":"2005","unstructured":"Schiepers OJ, Wichers MC, Maes M (2005) Cytokines and major depression. Prog Neuropsychopharmacol Biol Psychiatry 29:201\u2013217","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"28_CR80","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1176\/appi.ajp.162.1.175","volume":"162","author":"AJ Thomas","year":"2005","unstructured":"Thomas AJ, Davis S, Morris C et al (2005) Increase in interleukin-1beta in late-life depression. Am J Psychiatry 162:175\u2013177","journal-title":"Am J Psychiatry"},{"issue":"5","key":"28_CR81","doi-asserted-by":"publisher","first-page":"240","DOI":"10.3928\/00485713-20150501-06","volume":"45","author":"E Boorman","year":"2015","unstructured":"Boorman E, Romano GF, Russell A et al (2015) Are mood and anxiety disorders inflammatory diseases? Psychiatr Ann 45(5):240\u2013248","journal-title":"Psychiatr Ann"},{"key":"28_CR82","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1111\/j.1749-6632.2001.tb05827.x","volume":"933","author":"R Dantzer","year":"2001","unstructured":"Dantzer R (2001) Cytokine-induced sickness behavior: mechanisms and implications. Ann N Y Acad Sci 933:222\u2013234","journal-title":"Ann N Y Acad Sci"},{"key":"28_CR83","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1017\/S0033291704001953","volume":"34","author":"U Vollmer-Conna","year":"2004","unstructured":"Vollmer-Conna U, Fazou C, Cameron B et al (2004) Production of pro-inflammatory cytokines correlates with the symptoms of acute sickness behaviour in humans. Psychol Med 34:1289\u20131297","journal-title":"Psychol Med"},{"key":"28_CR84","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1016\/j.jpsychires.2006.06.009","volume":"41","author":"R K\u00e4nel von","year":"2006","unstructured":"von K\u00e4nel R, Hepp U, Kraemer B et al (2006) Evidence for low-grade systemic proinflammatory activity in patients with posttraumatic stress disorder. J Psychiatr Res 41:744\u2013752","journal-title":"J Psychiatr Res"},{"key":"28_CR85","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.biopsych.2009.09.033","volume":"67","author":"Y Dowlati","year":"2010","unstructured":"Dowlati Y, Herrmann N, Swardfager W et al (2010) A meta-analysis of cytokines in major depression. Biol Psychiatry 67:446\u2013457","journal-title":"Biol Psychiatry"},{"issue":"9","key":"28_CR86","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1016\/j.biopsych.2008.11.029","volume":"65","author":"AH Miller","year":"2009","unstructured":"Miller AH, Maletic V, Raison CL (2009) Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biol Psychiatry 65(9):732\u2013741","journal-title":"Biol Psychiatry"},{"key":"28_CR87","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/nri.2015.5","volume":"16","author":"AH Miller","year":"2016","unstructured":"Miller AH, Raison CL (2016) The role of inflammation in depression: from evolutionary imperative to modern treatment target. Nat Rev Immunol 16:23\u201334","journal-title":"Nat Rev Immunol"},{"key":"28_CR88","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/S1043-4666(03)00152-2","volume":"22","author":"A Iorio Di","year":"2003","unstructured":"Di Iorio A, Ferrucci L, Sparvieri E et al (2003) Serum IL-1beta levels in health and disease: a population-based study. \u2018The InCHIANTI study\u2019. Cytokine 22:198\u2013205","journal-title":"Cytokine"},{"key":"28_CR89","doi-asserted-by":"publisher","first-page":"e560","DOI":"10.1161\/01.CIR.0000148983.88334.80","volume":"110","author":"LM Biasucci","year":"2004","unstructured":"Biasucci LM (2004) CDC\/AHA Workshop on markers of inflammation and cardiovascular disease: application to clinical and public health practice: clinical use of inflammatory markers in patients with cardiovascular diseases: a background paper. Circulation 110:e560\u2013e567","journal-title":"Circulation"},{"key":"28_CR90","doi-asserted-by":"publisher","first-page":"2299","DOI":"10.1161\/01.CIR.0000164203.54111.AE","volume":"111","author":"JP Empana","year":"2005","unstructured":"Empana JP, Sykes DH, Luc G et al (2005) Contributions of depressive mood and circulating inflammatory markers to coronary heart disease in healthy European men: the Prospective Epidemiological Study of Myocardial Infarction (PRIME). Circulation 111:2299\u20132305","journal-title":"Circulation"},{"key":"28_CR91","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1097\/00001648-199307000-00003","volume":"4","author":"R Anda","year":"1993","unstructured":"Anda R, Williamson D, Jones D et al (1993) Depressed affect, hopelessness, and the risk of ischemic heart disease in a cohort of U.S. adults. Epidemiology 4:285\u2013294","journal-title":"Epidemiology"},{"key":"28_CR92","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1097\/01.hjr.0000188242.64590.92","volume":"13","author":"MH Kamphuis","year":"2006","unstructured":"Kamphuis MH, Kalmijn S, Tijhuis MA et al (2006) Depressive symptoms as risk factor of cardiovascular mortality in older European men: the Finland, Italy and Netherlands Elderly (FINE) study. Eur J Cardiovasc Prev Rehabil 13:199\u2013206","journal-title":"Eur J Cardiovasc Prev Rehabil"},{"key":"28_CR93","doi-asserted-by":"publisher","first-page":"3123","DOI":"10.1161\/01.CIR.94.12.3123","volume":"94","author":"LA Pratt","year":"1996","unstructured":"Pratt LA, Ford DE, Crum RM et al (1996) Depression, psychotropic medication, and risk of myocardial infarction. Prospective data from the Baltimore ECA follow-up. Circulation 94:3123\u20133129","journal-title":"Circulation"},{"issue":"7","key":"28_CR94","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1038\/sj.mp.4001805","volume":"11","author":"N M\u00fcller","year":"2006","unstructured":"M\u00fcller N, Schwarz MJ, Dehning S et al (2006) The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine. Mol Psychiatry 11(7):680\u2013684","journal-title":"Mol Psychiatry"},{"issue":"7","key":"28_CR95","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1002\/da.20589","volume":"26","author":"S Akhondzadeh","year":"2009","unstructured":"Akhondzadeh S, Jafari S, Raisi F et al (2009) Clinical trial of adjunctive celecoxib treatment in patients with major depression: a double blind and placebo controlled trial. Depress Anxiety 26(7):607\u2013611","journal-title":"Depress Anxiety"},{"issue":"2","key":"28_CR96","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1002\/hup.912","volume":"23","author":"FG Nery","year":"2008","unstructured":"Nery FG, Monkul ES, Hatch JP et al (2008) Celecoxib as an adjunct in the treatment of depressive or mixed episodes of bipolar disorder: a double-blind, randomized, placebo-controlled study. Hum Psychopharmacol 23(2):87\u201394","journal-title":"Hum Psychopharmacol"},{"key":"28_CR97","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.npbr.2014.01.151","volume":"20","author":"A Halaris","year":"2014","unstructured":"Halaris A, Alvi N, Meresh E, Sharma A (2014) Inflammation control reverses treatment-resistance in bipolar depression. Neurol Psychiatry Brain Res 20:12\u201313","journal-title":"Neurol Psychiatry Brain Res"},{"key":"28_CR98","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1016\/j.biopsych.2006.03.075","volume":"60","author":"H Himmerich","year":"2006","unstructured":"Himmerich H, Binder EB, K\u00fcnzel HE et al (2006) Successful antidepressant therapy restores the disturbed interplay between TNF-alpha system and HPA axis. Biol Psychiatry 60:882\u2013888","journal-title":"Biol Psychiatry"},{"key":"28_CR99","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1017\/S1461145702003164","volume":"5","author":"G Kenis","year":"2002","unstructured":"Kenis G, Maes M (2002) Effects of antidepressants on the production of cytokines. Int J Neuropsychopharmacol 5:401\u2013412","journal-title":"Int J Neuropsychopharmacol"},{"key":"28_CR100","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1097\/00004714-200104000-00012","volume":"21","author":"M Kubera","year":"2001","unstructured":"Kubera M, Lin AH, Kenis G et al (2001) Anti-inflammatory effects of antidepressants through suppression of the interferon-gamma\/interleukin-10 production ratio. J Clin Psychopharmacol 21:199\u2013206","journal-title":"J Clin Psychopharmacol"},{"key":"28_CR101","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.intimp.2003.11.006","volume":"4","author":"M Kubera","year":"2004","unstructured":"Kubera M, Kenis G, Bosmans E et al (2004) Stimulatory effect of antidepressants on the production of IL-6. Int Immunopharmacol 4:185\u2013192","journal-title":"Int Immunopharmacol"},{"key":"28_CR102","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.ijcard.2004.08.053","volume":"103","author":"B Mayer","year":"2005","unstructured":"Mayer B, Holmer SR, Hengstenberg C et al (2005) Functional improvement in heart failure patients treated with beta-blockers is associated with a decline of cytokine levels. Int J Cardiol 103:182\u2013186","journal-title":"Int J Cardiol"},{"key":"28_CR103","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1002\/hup.1103","volume":"25","author":"DG Janssen","year":"2010","unstructured":"Janssen DG, Caniato RN, Verster JC, Baune BT (2010) A psychoneuroimmunological review on cytokines involved in antidepressant treatment response. Human Psychopharmacol 25:201\u2013215","journal-title":"Human Psychopharmacol"},{"key":"28_CR104","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1007\/978-3-319-13602-8_16","volume-title":"Immunology and psychiatry, current topics in neurotoxicity","author":"A Halaris","year":"2015","unstructured":"Halaris A (2015) Do antidepressants exert effects on the immune system? In: Mueller N, Myint A-M, Schwarz MJ (eds) Immunology and psychiatry, current topics in neurotoxicity. Springer, Berlin, pp 339\u2013350. doi:\n                  10.1007\/978-3-319-13602-8_16"},{"key":"28_CR105","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1056\/NEJM199901143400207","volume":"340","author":"R Ross","year":"1999","unstructured":"Ross R (1999) Atherosclerosis-an inflammatory disease. N Engl J Med 340:115\u2013126","journal-title":"N Engl J Med"},{"key":"28_CR106","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/S0021-9150(03)00012-1","volume":"169","author":"L Lind","year":"2003","unstructured":"Lind L (2003) Circulating markers of inflammation and atherosclerosis. Atherosclerosis 169:203\u2013214","journal-title":"Atherosclerosis"},{"issue":"4","key":"28_CR107","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.biopsych.2006.09.029","volume":"62","author":"N Frasure-Smith","year":"2007","unstructured":"Frasure-Smith N, Lesp\u00e9rance F, Irwin MR et al (2007) Depression, C-reactive protein and two-year major adverse cardiac events in men after acute coronary syndromes. Biol Psychiatry 62(4):302\u2013308","journal-title":"Biol Psychiatry"},{"issue":"16","key":"28_CR108","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1056\/NEJMra043430","volume":"352","author":"G Hansson","year":"2005","unstructured":"Hansson G (2005) Inflammation, atherosclerosis and coronary artery disease. N Engl J Med 352(16):1685\u20131695","journal-title":"N Engl J Med"},{"key":"28_CR109","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/S1071-9164(96)80047-9","volume":"2","author":"Y Seta","year":"1996","unstructured":"Seta Y, Shan K, Bozkurt B et al (1996) Basic mechanisms in heart failure: the cytokine hypothesis. J Card Fail 2:243\u2013249","journal-title":"J Card Fail"},{"key":"28_CR110","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1111\/j.1527-5299.2006.05595.x","volume":"12","author":"JW Petersen","year":"2006","unstructured":"Petersen JW, Felker M (2006) Inflammatory biomarkers in heart failure. Congest Heart Fail 12:324\u2013328","journal-title":"Congest Heart Fail"},{"key":"28_CR111","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1111\/j.1365-2796.2008.02015.x","volume":"264","author":"JP Casas","year":"2008","unstructured":"Casas JP, Shah T, Hingorani AD et al (2008) C-reactive protein and coronary heart disease: a critical review. J Intern Med 264:295\u2013314","journal-title":"J Intern Med"},{"key":"28_CR112","doi-asserted-by":"publisher","first-page":"5126","DOI":"10.1016\/j.ijcard.2013.07.113","volume":"168","author":"W Koenig","year":"2013","unstructured":"Koenig W (2013) High-sensitivity C-reactive protein and atherosclerotic disease: from improved risk prediction to risk-guided therapy. Int J Cardiol 168:5126\u20135134","journal-title":"Int J Cardiol"},{"key":"28_CR113","doi-asserted-by":"publisher","first-page":"C19","DOI":"10.1016\/j.jacc.2005.10.066","volume":"47","author":"S Tsimikas","year":"2006","unstructured":"Tsimikas S, Willerson JT, Ridker PM (2006) C-reactive protein and other emerging blood biomarkers to optimize risk stratification of vulnerable patients. J Am Coll Cardiol 47:C19\u2013C31","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"28_CR114","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.bbi.2010.09.013","volume":"25","author":"M Hamer","year":"2011","unstructured":"Hamer M, Batty GD, Marmot MG et al (2011) Anti-depressant medication use and C-reactive protein: results from two population-based studies. Brain Behav Immun 25(1):168\u2013173","journal-title":"Brain Behav Immun"},{"issue":"2","key":"28_CR115","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1001\/2013.jamapsychiatry.102","volume":"70","author":"MK Wium-Andersen","year":"2013","unstructured":"Wium-Andersen MK, \u00d8rsted DD, Nielsen SF et al (2013) Elevated C-reactive protein levels, psychological distress, and depression in 73 131 Individuals. JAMA Psychiatry 70(2):176\u2013184","journal-title":"JAMA Psychiatry"},{"key":"28_CR116","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1097\/PSY.0b013e3181907c1b","volume":"71","author":"MB Howren","year":"2009","unstructured":"Howren MB, Lamkin DM, Suls J (2009) Associations of depression with C-reactive protein, IL-a, and IL-6: a meta-analysis. Psychosom Med 71:171\u2013186","journal-title":"Psychosom Med"},{"issue":"1","key":"28_CR117","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.biopsych.2011.09.023","volume":"71","author":"WE Copeland","year":"2012","unstructured":"Copeland WE, Shanahan L, Worthman C et al (2012) Cumulative depression episodes predict later C-reactive protein levels: a prospective analysis. Biol Psychiatry 71(1):15\u201321","journal-title":"Biol Psychiatry"},{"key":"28_CR118","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.bbi.2006.03.005","volume":"21","author":"MG Frank","year":"2007","unstructured":"Frank MG, Baratta MV, Sprunger DB et al (2007) Microglia serve as a neuroimmune substrate for stress-induced potentiation of CNS pro-inflammatory cytokine responses. Brain Behav Immun 21:47\u201359","journal-title":"Brain Behav Immun"},{"key":"28_CR119","unstructured":"Raison CL, Miller AH (2013) Do cytokines really sing the blues? Cerebrum: The Dana Foundation, p 1\u201316. \n                  http:\/\/dana.org\/Cerebrum\/2013\/Do_Cytokines_Really_Sing_the_Blues_\/#sthash.GLt3Sf7k.dpuf"},{"issue":"11","key":"28_CR120","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1515\/hsz-2015-0149","volume":"396","author":"Y Wu","year":"2015","unstructured":"Wu Y, Potempa LA, El Kebir D, Filep JG (2015) C-reactive protein and inflammation: conformational changes affect function. Biol Chem 396(11):1181\u20131197","journal-title":"Biol Chem"},{"key":"28_CR121","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1161\/01.ATV.0000051384.43104.FC","volume":"23","author":"PO Bonetti","year":"2003","unstructured":"Bonetti PO, Lerman LO, Lerman A (2003) Endothelial dysfunction: a marker of atherosclerotic risk. Arterioscler Thromb Vasc Biol 23:168\u2013175","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"28_CR122","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1042\/cs0980531","volume":"98","author":"SJ Cleland","year":"2000","unstructured":"Cleland SJ, Sattar N, Petrie JR et al (2000) Endothelial dysfunction as a possible link between C-reactive protein levels and cardiovascular disease. Clin Sci 98:531\u2013535","journal-title":"Clin Sci"},{"key":"28_CR123","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1176\/ajp.153.10.1313","volume":"153","author":"DL Musselman","year":"1996","unstructured":"Musselman DL, Tomer A, Manatunga AK et al (1996) Exaggerated platelet reactivity in major depression. Am J Psychiatry 153:1313\u20131317","journal-title":"Am J Psychiatry"},{"key":"28_CR124","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1001\/archpsyc.57.9.875","volume":"57","author":"DL Musselman","year":"2000","unstructured":"Musselman DL, Marzec UM, Manatunga A et al (2000) Platelet reactivity in depressed patients treated with paroxetine: preliminary findings. Arch Gen Psychiatry 57:875\u2013882","journal-title":"Arch Gen Psychiatry"},{"issue":"Suppl 4","key":"28_CR125","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1067\/mhj.2000.109978","volume":"140","author":"CB Nemeroff","year":"2000","unstructured":"Nemeroff CB, Musselman DL (2000) Are platelets the link between depression and ischemic heart disease? Am Heart J 140(Suppl 4):57\u201362","journal-title":"Am Heart J"},{"key":"28_CR126","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/S0022-3956(00)00034-0","volume":"34","author":"JE Piletz","year":"2000","unstructured":"Piletz JE, Zhu H, Madakasira S et al (2000) Elevated P-selectin on platelets in depression: response to bupropion. J Psychiatry Res 34:397\u2013404","journal-title":"J Psychiatry Res"},{"key":"28_CR127","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1097\/01.hjh.0000234111.31239.c3","volume":"24","author":"M Tucci","year":"2006","unstructured":"Tucci M, Quatraro C, Frassanito MA, Silvestris F (2006) Deregulated expression of monocyte chemoattractant protein-1 (MCP-1) in arterial hypertension: role in endothelial inflammation and atheromasia. J Hypertens 24:1307\u20131318","journal-title":"J Hypertens"},{"key":"28_CR128","doi-asserted-by":"publisher","first-page":"2054","DOI":"10.1161\/01.CIR.0000089191.72957.ED","volume":"108","author":"S Verma","year":"2003","unstructured":"Verma S, Buchanan MR, Anderson TJ (2003) Endothelial function testing as a biomarker of vascular disease. Circulation 108:2054\u20132059","journal-title":"Circulation"},{"key":"28_CR129","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1136\/heart.88.5.521","volume":"88","author":"AJ Broadley","year":"2002","unstructured":"Broadley AJ, Korszun A, Jones CJ, Frenneaux MP (2002) Arterial endothelial function is impaired in treated depression. Heart 88:521\u2013523","journal-title":"Heart"},{"issue":"8","key":"28_CR130","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/j.biopsych.2006.03.025","volume":"60","author":"JK Rybakowski","year":"2006","unstructured":"Rybakowski JK, Wykretowicz A, Heymann-Szlachcinska A, Wysocki H (2006) Impairment of endothelial function in unipolar and bipolar depression. Biol Psychiatry 60(8):889\u2013891","journal-title":"Biol Psychiatry"},{"key":"28_CR131","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1097\/PSY.0b013e3181e2cca5","volume":"72","author":"DP Do","year":"2010","unstructured":"Do DP, Dowd JB, Ranjit N et al (2010) Hopelessness, depression, and early markers of endothelial dysfunction in U.S. adults. Psychosom Med 72:613\u2013619","journal-title":"Psychosom Med"},{"issue":"5\u20136","key":"28_CR132","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/S0306-9877(03)00207-X","volume":"61","author":"AM Myint","year":"2003","unstructured":"Myint AM, Kim YK (2003) Cytokine-serotonin interaction through IDO; a neurodegeneration hypothesis of depression. Med Hypotheses 61(5\u20136):519\u2013525","journal-title":"Med Hypotheses"},{"issue":"1","key":"28_CR133","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.jad.2006.07.013","volume":"89","author":"AM Myint","year":"2007","unstructured":"Myint AM, Kim YK, Verkerk R et al (2007) Kynurenine pathway in major depression: evidence of impaired neuroprotection. J Affect Disord 89(1):143\u2013151","journal-title":"J Affect Disord"},{"key":"28_CR134","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1038\/mp.2009.116","volume":"15","author":"CL Raison","year":"2010","unstructured":"Raison CL, Dantzer R, Kelley KW et al (2010) CSF concentrations of brain tryptophan and kynurenines during immune stimulation with IFN-a: relationship to CNS immune responses and depression. Mol Psychiatry 15:393\u2013403","journal-title":"Mol Psychiatry"},{"key":"28_CR135","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.jpsychires.2015.04.026","volume":"66\u201367","author":"A Halaris","year":"2015","unstructured":"Halaris A, Myint AM, Savant V et al (2015) Does escitalopram reduce neurotoxicity in major depression? J Psychiatr Res 66\u201367:118\u2013126","journal-title":"J Psychiatr Res"},{"key":"28_CR136","doi-asserted-by":"publisher","first-page":"2510","DOI":"10.1038\/npp.2010.116","volume":"35","author":"C-B Zhu","year":"2010","unstructured":"Zhu C-B, Lindler KM, Owens AW et al (2010) Interleukin-1 receptor activation by systemic lipopolysaccharide induces behavioral despair linked to MAPK regulation of CNS serotonin transporters. Neuropsychopharmacology 35:2510\u20132520","journal-title":"Neuropsychopharmacology"},{"key":"28_CR137","doi-asserted-by":"publisher","DOI":"10.1038\/tp.2015.168","volume":"5","author":"NL Baganz","year":"2015","unstructured":"Baganz NL, Lindler KM, Zhu CB et al (2015) A requirement of serotonergic p38\u03b1 mitogen-activated protein kinase for peripheral immune system activation of CNS serotonin uptake and serotonin-linked behaviors. Transl Psychiatry 5, e671. doi:\n                  10.1038\/tp.2015.168","journal-title":"Transl Psychiatry"},{"issue":"3","key":"28_CR138","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1111\/bdi.12164","volume":"16","author":"JW Hsu","year":"2014","unstructured":"Hsu JW, Lirng JF, Wang SJ et al (2014) Association of thalamic serotonin transporter and interleukin-10 in bipolar I disorder: a SPECT study. Bipolar Disord 16(3):241\u2013248. doi:\n                  10.1111\/bdi.12164\n                  \n                , Epub 20 Dec 2013","journal-title":"Bipolar Disord"},{"issue":"4","key":"28_CR139","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1111\/jon.12035","volume":"23","author":"JD Amsterdam","year":"2013","unstructured":"Amsterdam JD, Newberg AB, Newman CF et al (2013) Change over time in brain serotonin transporter binding in major depression: effects of therapy measured with [123I]-ADAM SPECT. J Neuroimaging 23(4):469\u2013476. doi:\n                  10.1111\/jon.12035","journal-title":"J Neuroimaging"},{"key":"28_CR140","doi-asserted-by":"crossref","unstructured":"aan het Rot M, Collins KA, Murrough JW et al (2010) Safety and efficacy of repeated-dose intravenous ketamine for treatment-resistant depression. Biol Psychiatry 67:139\u2013145","DOI":"10.1016\/j.biopsych.2009.08.038"},{"key":"28_CR141","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/S0006-3223(99)00230-9","volume":"47","author":"RM Berman","year":"2000","unstructured":"Berman RM, Cappiello A, Anand A et al (2000) Antidepressant effects of ketamine in depressed patients. Biol Psychiatry 47:351\u2013354","journal-title":"Biol Psychiatry"},{"key":"28_CR142","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.neuropharm.2011.08.044","volume":"62","author":"RS Duman","year":"2012","unstructured":"Duman RS, Li N, Liu RJ et al (2012) Signaling pathways underlying the rapid antidepressant actions of ketamine. Neuropharmacology 62:35\u201341","journal-title":"Neuropharmacology"},{"key":"28_CR143","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.coph.2003.10.006","volume":"4","author":"R Schwarcz","year":"2004","unstructured":"Schwarcz R (2004) The kynurenine pathway of tryptophan degradation as a drug target. Curr Opin Pharmacol 4:12\u201317","journal-title":"Curr Opin Pharmacol"},{"key":"28_CR144","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/S0197-0186(01)00133-4","volume":"40","author":"RG Tavares","year":"2002","unstructured":"Tavares RG, Tasca CI, Santos CE et al (2002) Quinolinic acid stimulates synaptosomal glutamate release and inhibits glutamate uptake into astrocytes. Neurochem Int 40:621\u2013627","journal-title":"Neurochem Int"},{"key":"28_CR145","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/npp.2014.194","volume":"40","author":"J Savitz","year":"2015","unstructured":"Savitz J, Drevets WC, Smith CM et al (2015) Putative neuroprotective and neurotoxic kynurenine pathway metabolites are associated with hippocampal and amygdalar volumes in subjects with major depressive disorder. Neuropsychopharmacology 40:463\u2013471","journal-title":"Neuropsychopharmacology"},{"key":"28_CR146","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1038\/npp.2012.248","volume":"38","author":"S Erhardt","year":"2013","unstructured":"Erhardt S, Lim CK, Linderholm KR et al (2013) Connecting inflammation with glutamate agonism in suicidality. Neuropsychopharmacology 38:743\u2013752","journal-title":"Neuropsychopharmacology"},{"key":"28_CR147","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1007\/s00702-014-1187-1","volume":"121","author":"R Dantzer","year":"2014","unstructured":"Dantzer R, Walker A (2014) Is there a role for glutamate-mediated excitotoxicity in inflammation-induced depression? J Neural Transm (Vienna) 121:925\u2013932","journal-title":"J Neural Transm (Vienna)"},{"key":"28_CR148","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.neuint.2007.06.005","volume":"52","author":"E Malarkey","year":"2008","unstructured":"Malarkey E, Parpura V (2008) Mechanisms of glutamate release from astrocytes. Neurochem Int 52:142\u2013154","journal-title":"Neurochem Int"},{"key":"28_CR149","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1038\/nrn2911","volume":"11","author":"GE Hardingham","year":"2010","unstructured":"Hardingham GE, Bading H (2010) Synaptic versus extrasynaptic NMDA receptor signaling: implications for neurodegenerative disorders. Nat Rev Neurosci 11:682\u2013696","journal-title":"Nat Rev Neurosci"},{"key":"28_CR150","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1038\/npp.2013.140","volume":"38","author":"AH Miller","year":"2013","unstructured":"Miller AH (2013) Conceptual confluence: the kynurenine pathway as a common target for ketamine and the convergence of the inflammation and glutamate hypotheses of depression. Neuropsychopharmacology 38:1607\u20131608","journal-title":"Neuropsychopharmacology"},{"key":"28_CR151","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1038\/npp.2014.25","volume":"39","author":"E Haroon","year":"2014","unstructured":"Haroon E, Woolwine BJ, Chen X et al (2014) IFN-alpha induced cortical and subcortical glutamate changes assessed by magnetic resonance spectroscopy. Neuropsychopharmacology 39:1777\u20131785","journal-title":"Neuropsychopharmacology"},{"key":"28_CR152","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.bbi.2014.12.004","volume":"46","author":"E Haroon","year":"2015","unstructured":"Haroon E, Felger JC, Woolwine BJ et al (2015) Age-related increases in basal ganglia glutamate are associated with TNF, reduced motivation and decreased psychomotor speed during IFN-alpha treatment: preliminary findings. Brain Behav Immun 46:17\u201322","journal-title":"Brain Behav Immun"},{"key":"28_CR153","doi-asserted-by":"publisher","unstructured":"Haroon E, Fleischer CC, Felger JC et al (2016) Conceptual convergence: increased inflammation is associated with increased basal ganglia glutamate in patients with major depression. Molecular Psychiatry advance online publication, 12 Jan 2016. doi:\n                  10.1038\/mp.2015.206","DOI":"10.1038\/mp.2015.206"},{"key":"28_CR154","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pharmthera.2014.10.002","volume":"147","author":"J Haase","year":"2015","unstructured":"Haase J, Brown E (2015) Integrating the monoamine, neurotrophin and cytokine hypotheses of depression\u2014a central role for the serotonin transporter? Pharmacol Ther 147:1\u201311. doi:\n                  10.1016\/j.pharmthera.2014.10.002\n                  \n                , Epub 1 Nov 2014. Review","journal-title":"Pharmacol Ther"},{"issue":"9","key":"28_CR155","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1001\/archgenpsychiatry.2009.121","volume":"66","author":"AH Glassman","year":"2009","unstructured":"Glassman AH, Bigger TJ Jr, Gaffney M (2009) Psychiatric characteristics associated with long-term mortality among 361 patients having an acute coronary syndrome and major depression. Arch Gen Psychiatry 66(9):1022\u20131029","journal-title":"Arch Gen Psychiatry"},{"issue":"5","key":"28_CR156","doi-asserted-by":"publisher","first-page":"635","DOI":"10.2217\/fca.13.49","volume":"9","author":"A Halaris","year":"2013","unstructured":"Halaris A (2013) Psychocardiology: moving toward a new subspecialty. Future Cardiol 9(5):635\u2013640","journal-title":"Future Cardiol"}],"container-title":["Current Topics in Behavioral Neurosciences","Inflammation-Associated Depression: Evidence, Mechanisms and Implications"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/7854_2016_28","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,17]],"date-time":"2019-05-17T12:19:18Z","timestamp":1558095558000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/7854_2016_28"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"ISBN":["9783319511511","9783319511528"],"references-count":156,"URL":"https:\/\/doi.org\/10.1007\/7854_2016_28","relation":{},"ISSN":["1866-3370","1866-3389"],"issn-type":[{"value":"1866-3370","type":"print"},{"value":"1866-3389","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016]]},"assertion":[{"value":"10 November 2016","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}